Exagen (XGN) Cash from Investing Activities (2018 - 2026)
Exagen filings provide 9 years of Cash from Investing Activities readings, the most recent being -$228000.0 for Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 113.08% to -$228000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$747000.0, a 39.37% decrease, with the full-year FY2025 number at -$626000.0, down 21.55% from a year prior.
- Cash from Investing Activities hit -$228000.0 in Q1 2026 for Exagen, down from -$35000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$2000.0 in Q3 2023 to a low of -$1.9 million in Q2 2022.
- Median Cash from Investing Activities over the past 5 years was -$209000.0 (2025), compared with a mean of -$381823.5.
- Biggest five-year swings in Cash from Investing Activities: skyrocketed 99.77% in 2023 and later plummeted 7250.0% in 2024.
- Exagen's Cash from Investing Activities stood at -$406000.0 in 2022, then surged by 79.31% to -$84000.0 in 2023, then plummeted by 73.81% to -$146000.0 in 2024, then soared by 76.03% to -$35000.0 in 2025, then crashed by 551.43% to -$228000.0 in 2026.
- The last three reported values for Cash from Investing Activities were -$228000.0 (Q1 2026), -$35000.0 (Q4 2025), and -$275000.0 (Q3 2025) per Business Quant data.